Condition: PFIC - Progressive Familial Intrahepatic Cholestasis · Sponsor: Ipsen
Progressive Familial Intrahepatic Cholestasis (PFIC) is a group of inherited conditions that affect how bile moves in the liver, which can lead to serious liver problems. Doctors usually recommend genetic testing for patients with unexplained bile issues-after ruling out more common causes-to better understand the problem. However, there isn't much information on how common these genetic changes are in adults with these liver issues, especially in Spain. This study will observe these genetic changes so that doctors can diagnose the condition more clearly and create personalized treatment plans. This study will be conducted in several centers across Spain for 10 months. Each adult participant will take part in a single-day visit where their health information will be collected, and a blood sample will be taken for both routine tests and genetic analysis.
This description comes directly from the study's public registry record.
Ipsen Clinical Study Enquiries · See Email · clinical.trials@ipsen.com
Always discuss trial participation with your own doctor first.
| H. Clinic (first CEIm) | Barcelona, Spain | Recruiting |
| H. Vall Hebron | Barcelona, Spain | Recruiting |
| H. Reina Sofía | Córdoba, Spain | Recruiting |
| H. Dr. Negrín | Las Palmas, Spain | Recruiting |
| H. Gregorio Marañón | Madrid, Spain | Recruiting |
| Hospital Universitario La Paz | Madrid, Spain | Recruiting |
| H. Virgen del Rocío | Seville, Spain | Recruiting |
| H. La Fe | Valencia, Spain | Recruiting |
| H. Río Hortega | Valladolid, Spain | Recruiting |
| H. Miguel Servet | Zaragoza, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07191704